Introduction:
Kattanachampatty is a village located 293 kms from Chennai in South India [5] . This predominantly agrarian community belongs to the Namakkal district and comprises of people belonging to low socio-economic status [5] . Our study was conducted in this village. The reason for conducting the study in this village is because this village has a stable population with few people travelling in and out of the village. Hence there was minimal risk of infection being imported into this village from elsewhere. Also, though there are small hospitals in this village, people prefer traditional healers and native treatment for their illness. Hence more or less the population here is naïve to allopathic medicine. Also, this village was the birthplace of our institution's founder. Hence, this study also served as a charity-screening program for common illnesses to commemorate the birthday of our founder.
The villagers were informed about this charity clinic for the last 4 weeks prior to the study start through local radio advertisements, local newspapers and pamphlet distribution by social workers and village leaders. The first part of the study was conducted for 3 days (September 15 th to September 17 th 2012). Institutional review board of Sri Ramachandra University, Chennai, India, approved the study. The approval number is SRIRBPH10-12I. Only verbal consent was obtained from each participant in the study. Considering the low literacy level of the study participants it was considered inappropriate to get written consent from the study participants as they will be unable to read and understand the consent document. Instead a verbal consent was sought after explaining the entire study in the language that the study participants could understand and in front of the village leader; a person whom they trust. During these 3 days, 415 consecutive adults (age > 18 years) from this community who visited this charity clinic were screened. Though this charity clinic continued to screen almost 15,000
people, spread over the next 1 month for common acute and chronic illnesses, only the first 415 consecutive visitors to this charity clinic were screened for this study due to financial constraints.
Of these 415 participants screened, 20 participants were excluded because they had fever or respiratory illness during the previous 30 days or at the time of visit to the charity clinic, which was determined by symptom history and physical examination and 15 more, were excluded as they refused to provide consent for testing. Though it was not in our protocol to exclude pregnant women, we did not encounter any pregnant woman in these 415 people. Hence, after exclusion, 380 asymptomatic, community living adults aged > 18 years were included in the study and formed the study cohort. It is to be noted that none of these study participants ever received seasonal influenza vaccine or H1N1 influenza vaccine, as these vaccines were not commonly available in the village.
From these 380 study cohort participants demographic data (age, gender, current smoking, history of household contact with respiratory illness in the last 30 days, any allopathic or native medication intake in the last 30 days), vaccination history (pandemic H1N1 influenza vaccine and seasonal influenza vaccine in the last 3 years), clinical data (systolic and diastolic blood pressure, height, weight), laboratory data (fasting blood sugar, hemoglobin A1C% (HbA1C %), total white blood cell count, hemoglobin, serum creatinine, serum sodium, potassium, bicarbonate, total bilirubin, serum albumin, alkaline phosphatase and creatinine phosphokinase) were obtained. BMI was calculated as per standard guidelines [6] . A diagnosis of diabetes mellitus (DM) was made as per American Diabetes Association (ADA) guidelines [7] . Diagnosis of hypertension (HTN) was made as per Joint National Commission (JNC)
guidelines [8] . Throat swab (nasopharyngeal swab) was obtained from these 380 participants, stored at 2-4 degree centigrade and tested by RT-PCR for swine influenza A (HINI) as per CDC (Centers for Disease Control) protocol [9] . The study participants were tested only once. Those who tested positive were followed by weekly visits, for 4 weeks, to the charity clinic and questioned about symptoms of respiratory illness, and evaluated with clinical examinations which included respiratory system auscultations and throat and nose examinations with a standard torch light to see redness of the pharyngeal wall and nasal mucosa. These clinical exams were conducted by the same internist (first author) for all the positive patients. No laboratory testing was conducted during these follow-up weekly visits. To ensure 100% follow-up of people who tested positive, the study physician visited participants who were positive but did not come for weekly follow-up with a social worker at their homes and the above-mentioned exams were conducted at their homes. This ensured 100% follow-up of positive cases.
Statistical analysis
Baseline characteristics of study patients were expressed in number (%) for categorical variables, and as mean ± standard deviation for continuous variables. H1N1 influenza virus infection was coded as a categorical variable. At baseline, participants were categorized as those with H1N1 virus positive and H1N1 virus infection negative. Continuous and categorical variables were compared between these two groups at baseline using students 't' test or chi-square test as appropriate. Then uni-variate and multi-variate logistic regression analysis was performed using presence of H1N1 infection as the dependent variable and age, gender, BMI, diabetes diagnosis, and HbA1C% as independent variables. Since obesity [10] and diabetes mellitus [11] are known to be poor prognostic factors with symptomatic pandemic influenza infection, we included these variables in the logistic regression model to look for their association with asymptomatic carrier state. Though we planned Cox regression on the 4 weeks follow-up data, we could not perform these as none of the participants who were positive at baseline developed respiratory disease during 4 weeks of follow-up.
Results:
The baseline characteristics of the study cohort are detailed in (Table 2) . During the 4 weeks of follow-up none (0 out of 41) of the positive cases developed respiratory signs and symptoms of infection.
Discussion
Our study observed a significant prevalence (10.8%) of asymptomatic infection due to pandemic H1N1 influenza in a remote rural community of south India. It is interesting to note that this community represents a stable population, the village is self sustained and its inhabitants are predominantly agricultural workers and hence don't move out of the village often. Also, this remote rural village is not regularly visited by people from other areas. Hence, the probability of infection being imported from other areas is minimal. Also, it can be noted that none of the study participants had respiratory illness or had household contact with respiratory illness in the last 30 days (Table 1) . Hence, we can infer that the community as a whole had a low prevalence of symptomatic respiratory disease. Also, from Table 1 we understand that none of the study participants had received any medication for any illness in the last 30 days. Also, none of the study participants had received pandemic H1N1 influenza or seasonal influenza vaccines. Also, the fact that 16.3% and 10.5% of the study cohort had a diagnosis of incident DM and incident HTN (Table 1) proves that this community had been far from the influence of modern medicine.
This being the case it is not clear as to why the prevalence of asymptomatic infection due to pandemic H1N1 influenza be so high.
Further, factors such as diabetes [11] , obesity [10] and age [12] which are poor prognostic indicators in symptomatic pandemic H1N1 influenza infection were not associated with asymptomatic carrier state in our study (Table 2 ). In fact none of the patient characteristics were significantly associated with having asymptomatic carrier state (Table 2) .
Annual symptomatic seasonal influenza rates and symptomatic pandemic H1N1 influenza rates during the epidemic and the period after that for this village and the surrounding areas has not been reported. Further, similar to the scarcity of data the world over for asymptomatic pandemic H1N1 influenza rates, this data is not known for this village and the surrounding areas.
The relevance of asymptomatic pandemic H1N1 influenza virus carrier state in this population is not clear. None of the 41 positive participants developed symptomatic illness in the 4 weeks of follow-up. It is hard to comment if this observation represents the way an epidemic dies down in the community or it represents the beginning of a new epidemic. Since there are no comparison studies it is hard to arrive at an inference.
Limitations:
Small sample size is an important limitation of our study. This affects precision of our estimates
and limits our ability to analyze effect modification due to patient characteristics. Also, we could 
Conclusions:
We observed a significant prevalence of asymptomatic carrier state due to pandemic H1N1 influenza virus in a remote rural community of South India. The relevance of this high prevalence of asymptomatic infection at a time when the global pandemic had been controlled remains unclear.
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